Meet Our New CEO, Simone Grapini-Goodman

Business Insider Investigates Surge in Insulin Pricing

Written by: Beyond Type 1 Editorial Team

1 minute read

September 20, 2016

Beyond Type 1 CEO Sarah Lucas discusses the recent spike in insulin costs and the issue of access to this life-saving medication in Business Insider. Although the drug has been around for 93 years, it can cost a family more than a mortgage payment to get it. Read as to why this is happening and how families are forced to cope.

Beyond Type 1 CEO Sarah Lucas discusses the recent spike in insulin costs and the issue of access to this life-saving medication in Business Insider. Although the drug has been around for 93 years, it can cost a family more than a mortgage payment to get it. Read as to why this is happening and how families are forced to cope.

Beyond Type 1

Author

Beyond Type 1 Editorial Team

Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research. Find industry news, inspirational stories and practical help. Join the 1M+ strong community and discover what it means to #LiveBeyond a diabetes diagnosis.